Hypothesis: Descending vagal-orexin signaling gates intestinal ERK1/2 nuclear import to suppress stem cell senescence

Background Recent work highlights that gut-derived signals set the brain’s homeostatic baseline, yet the complementary efferent arm—brain‑to‑gut communication—remains untested in aging contexts 1. The vagus nerve provides cholinergic input to the intestinal crypts, and muscarinic receptor activation can modulate the ERK1/2 import machinery that controls nuclear translocation of phosphorylated ERK 2. Age‑related loss of orexin‑producing neurons in the lateral hypothalamus reduces vagal efferent firing, a change documented in multiple models of frailty 3.

Mechanistic basis We propose that diminished orexin‑driven vagal tone lowers acetylcholine release in the gut, leading to decreased signaling through M3 muscarinic receptors on intestinal stem cells (ISCs). M3 coupling to Gq/11 activates phospholipase Cβ, producing IP3 and DAG, which stimulate PKC‑dependent pathways that promote ERK1/2 nuclear import complex activity (e.g., importin‑7 phosphorylation). When this pathway is weak, p‑ERK1/2 accumulates in the cytoplasm, sustaining transcription of p21 and SASP factors and driving ISC senescence 2. Conversely, robust vagal‑orexin signaling promotes ERK nuclear entry, allowing transient ERK activity to support proliferation without triggering the senescence program.

Testable predictions

1. Aged mice with chemogenetic inhibition of lateral hypothalamus orexin neurons will show reduced vagal efferent activity (measured by colonic cholinergic tone) and increased cytoplasmic p‑ERK1/2 in ISCs compared with controls.
2. Restoring vagal efferent output via optogenetic stimulation of the dorsal motor nucleus of the vagus (DMV) will rescue nuclear p‑ERK1/2 levels, decrease p21^Waf1/Cip1^ expression, and enhance crypt proliferation in aged animals.
3. Pharmacological blockade of M3 receptors in young mice will mimic the aged phenotype: cytoplasmic ERK retention, elevated senescence markers, and delayed epithelial repair after dextran sulfate sodium‑induced colitis.
4. Genetic overexpression of a constitutively nuclear ERK1/2 mutant in ISCs will bypass the need for vagal input, maintaining low senescence scores even when orexin signaling is suppressed.

Experimental approach

• Use Cre‑dependent hM4Di DREADDs in orexin neurons of adult mice; administer CNO at 6, 12, and 18 months to inhibit firing. Collect colonic tissue for immunohistochemistry of choline acetyltransferase (ChAT) to confirm vagal tone, and immunofluorescence for p‑ERK1/2 localization in Lgr5^+ ISCs.
• In a separate cohort, express ChR2 in DMV vagal preganglionic neurons; deliver 473 nm light pulses via implanted fiber to stimulate efferent firing during the same age windows.
• Treat groups with the M3 antagonist tropicamide or vehicle; assess senescence via SA‑β‑gal staining, p21 Western blot, and EdU incorporation after injury.
• Introduce a ERK1/2‑NLS‑GFP construct using Lgr5‑CreERT2 to force nuclear localization; compare senescence readouts with and without orexin inhibition.

Potential confounders and controls

• Systemic effects of CNO/clozapine must be ruled out using appropriate control viruses and saline injections.
• Off‑target cholinergic drugs will be paired with atropine to verify muscarinic specificity.
• Microbiota alterations will be monitored by 16S rRNA sequencing to ensure observed changes are not secondary to dysbiosis.

If these experiments confirm that descending vagal‑orexin tone regulates ERK1/2 nuclear shuttling in the gut, it would invert the prevailing gut‑centric view of aging and reveal a neuromodulatory lever for intestinal regeneration.